These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 21518438)

  • 1. Systems biology approach to identify transcriptome reprogramming and candidate microRNA targets during the progression of polycystic kidney disease.
    Pandey P; Qin S; Ho J; Zhou J; Kreidberg JA
    BMC Syst Biol; 2011 Apr; 5():56. PubMed ID: 21518438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallel analysis of mRNA and microRNA microarray profiles to explore functional regulatory patterns in polycystic kidney disease: using PKD/Mhm rat model.
    Dweep H; Sticht C; Kharkar A; Pandey P; Gretz N
    PLoS One; 2013; 8(1):e53780. PubMed ID: 23326503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA helicase p68 inhibits the transcription and post-transcription of
    Zhang L; Li LX; Zhou JX; Harris PC; Calvet JP; Li X
    Theranostics; 2020; 10(18):8281-8297. PubMed ID: 32724471
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative transcriptomics of shear stress treated Pkd1
    Kunnen SJ; Malas TB; Formica C; Leonhard WN; 't Hoen PAC; Peters DJM
    Biomed Pharmacother; 2018 Dec; 108():1123-1134. PubMed ID: 30372813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of pathological transcription in autosomal dominant polycystic kidney disease epithelia.
    Friedrich S; Müller H; Riesterer C; Schüller H; Friedrich K; Wörner CL; Busch T; Viau A; Kuehn EW; Köttgen M; Hofherr A
    Sci Rep; 2021 Jul; 11(1):15139. PubMed ID: 34301992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global microRNA profiling in human urinary exosomes reveals novel disease biomarkers and cellular pathways for autosomal dominant polycystic kidney disease.
    Magayr TA; Song X; Streets AJ; Vergoz L; Chang L; Valluru MK; Yap HL; Lannoy M; Haghighi A; Simms RJ; Tam FWK; Pei Y; Ong ACM
    Kidney Int; 2020 Aug; 98(2):420-435. PubMed ID: 32622528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The master regulators Myc and p53 cellular signaling and functions in polycystic kidney disease.
    Kurbegovic A; Trudel M
    Cell Signal; 2020 Jul; 71():109594. PubMed ID: 32145315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin-Dependent Kinase 1 Activity Is a Driver of Cyst Growth in Polycystic Kidney Disease.
    Zhang C; Balbo B; Ma M; Zhao J; Tian X; Kluger Y; Somlo S
    J Am Soc Nephrol; 2021 Jan; 32(1):41-51. PubMed ID: 33046531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pkd1-targeted mutation reveals a role for the Wolffian duct in autosomal dominant polycystic kidney disease.
    Tee JB; Dnyanmote AV; Lorenzo MK; Lee OR; Grisaru S; Suk M; Acott PD
    J Dev Orig Health Dis; 2020 Feb; 11(1):78-85. PubMed ID: 31412963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of KLF12 by microRNA-20b and microRNA-106a in cystogenesis.
    Shin Y; Kim DY; Ko JY; Woo YM; Park JH
    FASEB J; 2018 Jul; 32(7):3574-3582. PubMed ID: 29475398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion.
    Wilk EJ; Howton TC; Fisher JL; Oza VH; Brownlee RT; McPherson KC; Cleary HL; Yoder BK; George JF; Mrug M; Lasseigne BN
    Mol Med; 2023 May; 29(1):67. PubMed ID: 37217845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide methylation profiling of ADPKD identified epigenetically regulated genes associated with renal cyst development.
    Woo YM; Bae JB; Oh YH; Lee YG; Lee MJ; Park EY; Choi JK; Lee S; Shin Y; Lyu J; Jung HY; Lee YS; Hwang YH; Kim YJ; Park JH
    Hum Genet; 2014 Mar; 133(3):281-97. PubMed ID: 24129831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the timing and magnitude of Pkd1 gene deletion determine the severity of polycystic kidney disease in an orthologous mouse model of ADPKD.
    Rogers KA; Moreno SE; Smith LA; Husson H; Bukanov NO; Ledbetter SR; Budman Y; Lu Y; Wang B; Ibraghimov-Beskrovnaya O; Natoli TA
    Physiol Rep; 2016 Jun; 4(12):. PubMed ID: 27356569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablation of Long Noncoding RNA Hoxb3os Exacerbates Cystogenesis in Mouse Polycystic Kidney Disease.
    Weisser I; Eckberg K; D'Amico S; Buttram D; Aboudehen K
    J Am Soc Nephrol; 2024 Jan; 35(1):41-55. PubMed ID: 37953472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of polycystic kidney disease by non-coding RNAs.
    Ramalingam H; Yheskel M; Patel V
    Cell Signal; 2020 Jul; 71():109548. PubMed ID: 31982550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross talk between lysine methyltransferase Smyd2 and TGF-β-Smad3 signaling promotes renal fibrosis in autosomal dominant polycystic kidney disease.
    Li LX; Zhang L; Agborbesong E; Zhang X; Zhou JX; Li X
    Am J Physiol Renal Physiol; 2022 Aug; 323(2):F227-F242. PubMed ID: 35759739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated TGFbeta-Smad signalling in experimental Pkd1 models and human patients with polycystic kidney disease.
    Hassane S; Leonhard WN; van der Wal A; Hawinkels LJ; Lantinga-van Leeuwen IS; ten Dijke P; Breuning MH; de Heer E; Peters DJ
    J Pathol; 2010 Sep; 222(1):21-31. PubMed ID: 20549648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling of miRNAs and target genes related to cystogenesis in ADPKD mouse models.
    Woo YM; Kim DY; Koo NJ; Kim YM; Lee S; Ko JY; Shin Y; Kim BH; Mun H; Choi S; Lee EJ; Shin JO; Park EY; Bok J; Park JH
    Sci Rep; 2017 Oct; 7(1):14151. PubMed ID: 29074972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of transcription factor profiles in polycystic kidney disease (PKD): identification and validation of STAT3 and RUNX1 in the injury/repair response and PKD progression.
    Formica C; Malas T; Balog J; Verburg L; 't Hoen PAC; Peters DJM
    J Mol Med (Berl); 2019 Dec; 97(12):1643-1656. PubMed ID: 31773180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parallel microarray profiling identifies ErbB4 as a determinant of cyst growth in ADPKD and a prognostic biomarker for disease progression.
    Streets AJ; Magayr TA; Huang L; Vergoz L; Rossetti S; Simms RJ; Harris PC; Peters DJ; Ong AC
    Am J Physiol Renal Physiol; 2017 Apr; 312(4):F577-F588. PubMed ID: 28077374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.